Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PKCβII activation requires nuclear trafficking for phosphorylation and Mdm2-mediated ubiquitination. | Life Sci Alliance | 2023 | 36717249 | PubTator, text mining | PubMed |
| Non-coding RNAs regulate mitochondrial dynamics in the development of gastric cancer. | Front Mol Biosci | 2023 | 36714260 | PubTator, text mining | PubMed |
| Activation of long-non-coding RNA NEAT1 sponging microRNA-147 inhibits radiation damage by targeting PDPK1 in troxerutin radioprotection. | iScience | 2023 | 36698722 | PubTator, text mining | PubMed |
| Endo-Lysosomal and Autophagy Pathway and Ubiquitin-Proteasome System in Mood Disorders: A Review Article. | Neuropsychiatr Dis Treat | 2023 | 36684613 | PubTator, text mining | PubMed |
| Nano-Zirconium Dioxide Catalyzed Multicomponent Synthesis of Bioactive Pyranopyrazoles That Target Cyclin Dependent Kinase 1 in Human Breast Cancer Cells. | Biomedicines | 2023 | 36672680 | PubTator, text mining | PubMed |
| The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers. | Biomolecules | 2023 | 36671552 | PubTator, text mining | PubMed |
| Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems. | Curr Oncol | 2023 | 36661704 | PubTator, text mining | PubMed |
| A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics. | Commun Biol | 2023 | 36653408 | PubTator, text mining | PubMed |
| LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing. | Clin Transl Med | 2023 | 36650118 | PubTator, text mining | PubMed |
| Ancestral origins are associated with SARS-CoV-2 susceptibility and protection in a Florida patient population. | PLoS One | 2023 | 36649279 | PubTator, text mining | PubMed |
| Melatonin as a Repurposed Drug for Melanoma Treatment. | Med Sci (Basel) | 2023 | 36649046 | PubTator, text mining | PubMed |
| Characterisation of Colorectal Cancer Cell Lines through Proteomic Profiling of Their Extracellular Vesicles. | Proteomes | 2023 | 36648961 | PubTator, text mining | PubMed |
Investigation of the Effects of Glabridin on the Proliferation, Apoptosis, and Migration of the Human Colon Cancer Cell Lines SW480 and SW620 and Its Mechanism Based on Reverse Virtual Screening and Proteomics. | Oxid Med Cell Longev | 2023 | 36644579 | PubTator, text mining | PubMed |
| An atlas of substrate specificities for the human serine/threonine kinome. | Nature | 2023 | 36631611 | PubTator, text mining | PubMed |
| Evaluation of the Anticancer and Probiotic Potential of Autochthonous (Wild) Lacticaseibacillus paracasei Strains from New Ecological Niches as a Possible Additive for Functional Dairy Foods. | Foods | 2023 | 36613399 | PubTator, text mining | PubMed |
| Synthesize heterogeneous biological knowledge via representation learning for Alzheimer's disease drug repurposing. | iScience | 2023 | 36594024 | PubTator, text mining | PubMed |
| The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development. | Emerg Microbes Infect | 2023 | 36583642 | PubTator, text mining | PubMed |
| Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review). | Int J Oncol | 2023 | 36562354 | PubTator, text mining | PubMed |
Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial. | EClinicalMedicine | 2023 | 36471691 | PubTator, text mining | PubMed |
| Systematic identification of biochemical networks in cancer cells by functional pathway inference analysis. | Bioinformatics | 2023 | 36448701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers?page=16